Full Year Results 

Mediclinic takes Middle East writedown

Mediclinic takes Middle East writedown

March is the final, and typically strongest, month of Mediclinic’s (MDC) financial year. But the transition into the first quarter of FY2021 has played out rather differently for the private hospital operator. Widespread lockdowns and the postponement of non-urgent procedures saw revenues for April drop by more than a third. A high fixed cost base meant that earnings were also badly hit – with a monthly cash loss of £20m, against a profit of £40m in April 2019.

To continue reading, subscribe today

and enjoy unlimited access to the following:

  • Tips of the Week
  • Funds coverage
  • Weekly features on big investment themes
  • Trading ideas
  • Comprehensive companies coverage
  • Economic analysis
Subscribe
Subscribe to Investors Chronicle

Subscribe today

Full access for just £3.37 a week:

• Tips and recommendations - to beat the market 
• Portfolio clinic & Mr Bearbull - build a well-planned portfolio 
• Expert tools - track and manage investments effortlessly
• Plus free delivery to your home or office

Subscribe Now